Presentation

Most skincare products fail to work as promised; only 1-5% of active ingredients penetrate the skin’s outer layer. This limits complex treatments like gene therapies or mRNA-based treatments for conditions such as eczema or skin aging, resulting in ineffective results and high costs. We have developed the Spiked Microspheres platform to solve this by creating temporary pathways in the skin. The ingredient can be added to any cream, boosting ingredient delivery by up to 100x, enabling Next Generation Dermatology. We’ve drastically reduced production costs by 90% and are preparing to scale, starting with cosmetics, then expanding into pharmaceuticals. The project is now focused on ramping up production and initiating customer pilots with global leaders to develop platform-powered formulations. Picture: 15 individual microspheres on a fingertip to illustrate their size. In a final cream formulation, these microspheres will be added during manufacturing to enhance the cream’s effectiveness.